Insufficient scRNA-seq data for expression of DHX58 at single-cell level.
Insufficient scRNA-seq data for expression of DHX58 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 1607.05 | 245 / 245 | 100% | 24.32 | 501 / 502 |
kidney | 100% | 1224.18 | 89 / 89 | 99% | 18.29 | 894 / 901 |
breast | 100% | 1220.77 | 459 / 459 | 98% | 25.87 | 1099 / 1118 |
bladder | 100% | 1222.29 | 21 / 21 | 97% | 18.85 | 488 / 504 |
uterus | 100% | 1261.17 | 170 / 170 | 97% | 19.78 | 443 / 459 |
lung | 100% | 1480.45 | 578 / 578 | 96% | 18.07 | 1113 / 1155 |
liver | 100% | 1433.22 | 226 / 226 | 96% | 14.08 | 388 / 406 |
esophagus | 100% | 924.38 | 1441 / 1445 | 96% | 14.31 | 175 / 183 |
brain | 99% | 695.26 | 2620 / 2642 | 96% | 16.73 | 678 / 705 |
pancreas | 97% | 488.61 | 318 / 328 | 98% | 21.41 | 175 / 178 |
skin | 99% | 813.06 | 1787 / 1809 | 96% | 19.34 | 451 / 472 |
stomach | 99% | 918.13 | 357 / 359 | 94% | 11.00 | 268 / 286 |
thymus | 100% | 965.17 | 650 / 653 | 94% | 16.79 | 566 / 605 |
intestine | 100% | 1109.57 | 966 / 966 | 92% | 11.04 | 487 / 527 |
adrenal gland | 100% | 1835.93 | 258 / 258 | 92% | 12.61 | 212 / 230 |
ovary | 100% | 1487.28 | 180 / 180 | 89% | 11.88 | 383 / 430 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.84 | 29 / 29 |
spleen | 100% | 1963.53 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.25 | 1 / 1 |
blood vessel | 100% | 935.71 | 1333 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 1091.51 | 1202 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 12.07 | 78 / 80 |
tonsil | 0% | 0 | 0 / 0 | 96% | 19.91 | 43 / 45 |
peripheral blood | 95% | 1091.23 | 884 / 929 | 0% | 0 | 0 / 0 |
heart | 92% | 396.72 | 788 / 861 | 0% | 0 | 0 / 0 |
muscle | 58% | 177.31 | 469 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0009617 | Biological process | response to bacterium |
GO_0009615 | Biological process | response to virus |
GO_0032481 | Biological process | positive regulation of type I interferon production |
GO_0039536 | Biological process | negative regulation of RIG-I signaling pathway |
GO_0039534 | Biological process | negative regulation of MDA-5 signaling pathway |
GO_0032480 | Biological process | negative regulation of type I interferon production |
GO_0045088 | Biological process | regulation of innate immune response |
GO_0045824 | Biological process | negative regulation of innate immune response |
GO_1900246 | Biological process | positive regulation of RIG-I signaling pathway |
GO_1900245 | Biological process | positive regulation of MDA-5 signaling pathway |
GO_0002753 | Biological process | cytoplasmic pattern recognition receptor signaling pathway |
GO_0140374 | Biological process | antiviral innate immune response |
GO_0005737 | Cellular component | cytoplasm |
GO_0003677 | Molecular function | DNA binding |
GO_0003727 | Molecular function | single-stranded RNA binding |
GO_0003724 | Molecular function | RNA helicase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0003725 | Molecular function | double-stranded RNA binding |
Gene name | DHX58 |
Protein name | RNA helicase (EC 3.6.4.13) ATP-dependent RNA helicase DHX58 (EC 3.6.4.13) (ATP-dependent helicase LGP2) (Protein D11Lgp2 homolog) (RIG-I-like receptor 3) (RLR-3) (RIG-I-like receptor LGP2) (RLR) DExH-box helicase 58 |
Synonyms | hCG_15679 LGP2 D11LGP2E |
Description | FUNCTION: Acts as a regulator of RIGI and IFIH1/MDA5 mediated antiviral signaling. Cannot initiate antiviral signaling as it lacks the CARD domain required for activating MAVS/IPS1-dependent signaling events. Can have both negative and positive regulatory functions related to RIGI and IFIH1/MDA5 signaling and this role in regulating signaling may be complex and could probably depend on characteristics of the infecting virus or target cells, or both. Its inhibitory action on RIG-I signaling may involve the following mechanisms: competition with RIGI for binding to the viral RNA, binding to RIGI and inhibiting its dimerization and interaction with MAVS/IPS1, competing with IKBKE in its binding to MAVS/IPS1 thereby inhibiting activation of interferon regulatory factor 3 (IRF3). Its positive regulatory role may involve unwinding or stripping nucleoproteins of viral RNA thereby facilitating their recognition by RIGI and IFIH1/MDA5. Involved in the innate immune response to various RNA viruses and some DNA viruses such as poxviruses and coronavirus SARS-CoV-2, and also to the bacterial pathogen Listeria monocytogenes . Can bind both ssRNA and dsRNA, with a higher affinity for dsRNA. Shows a preference to 5'-triphosphorylated RNA, although it can recognize RNA lacking a 5'-triphosphate. . |
Accessions | ENST00000413196.6 ENST00000430773.1 C9JG98 K7EPP0 ENST00000589979.1 K7EMZ5 ENST00000591220.5 Q96C10 A0AA51U9C6 C9JE76 ENST00000251642.8 |